Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 609
Selected: 0
NCT IDTitle
NCT04245397Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
NCT01176474Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma
NCT04585269Bright IDEAS - Young Adults Problem-Solving Skills Training
NCT06497569Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer
NCT05358938Exercise to Boost Response to Checkpoint Blockade Immunotherapy
NCT06734130Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer
NCT01350583Bicarbonate for Tumor Related Pain
NCT06047977Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors
NCT04275557Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
NCT06253845Study of CG0070 After Transurethral Resection in Patients With IR NMIBC
NCT00496223A Phase I/II Study of Sunitinib and Dacarbazine
NCT02063724HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer
NCT02652455Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma
NCT01423578Effects of Yoga and Cardiovascular Exercise on Smoking Motivation
NCT03514017Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia
NCT05064085Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer
NCT00617617The Specific Role of Isoflavones in Reducing Prostate Cancer Risk
NCT01657591Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma
NCT05763563Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy
NCT06144619Non-Invasive Biomarkers in Prostate Cancer Disease Management
NCT03807765Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
NCT02440425Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer
NCT00361140Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
NCT02981797Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223
NCT03112590Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer
NCT01859026A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation
NCT00606008A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
NCT02202499Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence
NCT03870399Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression
NCT00609765Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors
NCT07030400Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
NCT04101422Utilizing Augmented Reality as an Adjunct for Smoking Cessation
NCT02416011Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes
NCT00101101Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma
NCT00596011Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia
NCT06844097Intervention for Medical Student to Promote Cervical Cancer Screening Among Latinx Transmasculine Individuals
NCT00215956A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
NCT00665002Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms
NCT00720096Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan
NCT00823511The Human Papillomavirus (HPV) Transmission Pilot Study
NCT04257474Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk
NCT00006376R115777 in Treating Patients With Advanced Bladder Cancer
NCT02466568Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung
NCT03686488TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
NCT07529405A Study of VG712 in Patients With Mycosis Fungoides
NCT02115542Single Agent Regorafenib in Refractory Advanced Biliary Cancers
NCT06833502Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
NCT03977402Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
NCT00215995Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas
NCT00400569Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma